1.0Pharma Trendhttps://pharma-trend.com/enEditorial staffhttps://pharma-trend.com/en/author/redaktion/Jorveza®: Innovation through ingenious galenics - Pharma Trendrich600338<blockquote class="wp-embedded-content" data-secret="rgqVvWcIK5"><a href="https://pharma-trend.com/en/jorveza/">Jorveza®: Innovation through ingenious galenics</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pharma-trend.com/en/jorveza/embed/#?secret=rgqVvWcIK5" width="600" height="338" title="“Jorveza®: Innovation through ingenious galenics” — Pharma Trend" data-secret="rgqVvWcIK5" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://pharma-trend.com/en/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, which can be effectively treated with topical steroids. Yet until recently, no mode of administration had been approved and optimised specifically for EoE. This gap has now been closed by the new budesonide orodispersible tablet (with effervescent quality) Jorveza®, which gastroenterologists considered the ... [Read more...]https://pharma-trend.com/wp-content/uploads/2018/10/Jorveza-das-innovativste-produkt-gastroenterologen-2018-300x151.png